Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (101-110 of 205) with videos related to

Pageof 21
Sort By:
Radiology|March 25, 2016
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term ResultsOlivier Seror, Gisèle N'Kontchou, Jean-Charles Nault, et al.
Journal of Hepatocellular Carcinoma|January 4, 2023
Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular CarcinomaNesrine Mouhoubi, Jessica Bamba-Funck, Angela Sutton, et al.
Journal of Hepatology|November 25, 2022
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosisPierre Nahon, Jessica Bamba-Funck, Richard Layese, et al.
Journal of Hepatology|September 13, 2011
A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Radiology|April 29, 2017
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case SeriesOlivier Sutter, Joyce Calvo, Gisèle N'Kontchou, et al.
Journal of Hepatology|February 28, 2023
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillanceAmit G Singal, Marco Sanduzzi-Zamparelli, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|February 8, 2017
Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver diseaseSebastian Mueller, Pierre Nahon, Vanessa Rausch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2020
Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require TreatmentArthur Berger, Federico Ravaioli, Oana Farcau, et al.
Clinics and Research in Hepatology and Gastroenterology|April 26, 2022
Comparison of screening strategies with two new tests to score and diagnose varices needing treatmentPaul Calès, Federico Ravaioli, Arthur Berger, et al.
Journal of Gastroenterology and Hepatology|June 26, 2019
Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosisSamia Rekik, Manon Allaire, Annie Mumana, et al.
Pageof 21

Showing results (101-110 of 205) with videos related to

Sort By:
Pageof 21
Radiology|March 25, 2016
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term ResultsOlivier Seror, Gisèle N'Kontchou, Jean-Charles Nault, et al.
Journal of Hepatocellular Carcinoma|January 4, 2023
Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular CarcinomaNesrine Mouhoubi, Jessica Bamba-Funck, Angela Sutton, et al.
Journal of Hepatology|November 25, 2022
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosisPierre Nahon, Jessica Bamba-Funck, Richard Layese, et al.
Journal of Hepatology|September 13, 2011
A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Radiology|April 29, 2017
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case SeriesOlivier Sutter, Joyce Calvo, Gisèle N'Kontchou, et al.
Journal of Hepatology|February 28, 2023
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillanceAmit G Singal, Marco Sanduzzi-Zamparelli, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|February 8, 2017
Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver diseaseSebastian Mueller, Pierre Nahon, Vanessa Rausch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2020
Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require TreatmentArthur Berger, Federico Ravaioli, Oana Farcau, et al.
Clinics and Research in Hepatology and Gastroenterology|April 26, 2022
Comparison of screening strategies with two new tests to score and diagnose varices needing treatmentPaul Calès, Federico Ravaioli, Arthur Berger, et al.
Journal of Gastroenterology and Hepatology|June 26, 2019
Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosisSamia Rekik, Manon Allaire, Annie Mumana, et al.
Pageof 21